BRIEF-DocGo Q3 Revenue USD 138.7 Million Vs. IBES Estimate USD 137.9 Million
Nov 07 (Reuters) - DocGo Q3 gross margin 33%.
- Q3 adjusted EBITDA USD 17.9 million vs. IBES estimate USD 13.6 million
- Q3 net income USD 4.5 million vs. IBES estimate USD 4.35 million
- outlook FY adjusted EBITDA USD 70-75 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments